These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Natalizumab in the treatment of multiple sclerosis]. Horga A, Horga de la Parte JF. Rev Neurol; 2008 Aug; 45(5):293-303. PubMed ID: 17876741 [Abstract] [Full Text] [Related]
9. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C. N Engl J Med; 2012 May 17; 366(20):1870-80. PubMed ID: 22591293 [Abstract] [Full Text] [Related]
10. Natalizumab (Tysabri) returns. Med Lett Drugs Ther; 2006 Sep 11; 48(1243):76. PubMed ID: 16977289 [No Abstract] [Full Text] [Related]
11. [New drugs; natalizumab]. van Bronswijk H, Dubois EA, van Gerven JM, Cohen AF. Ned Tijdschr Geneeskd; 2008 Mar 01; 152(9):499-500. PubMed ID: 18389881 [Abstract] [Full Text] [Related]
12. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. N Engl J Med; 2005 Jul 28; 353(4):375-81. PubMed ID: 15947078 [Abstract] [Full Text] [Related]
13. Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option? Maillart E, Louapre C, Lubetzki C, Papeix C. Mult Scler; 2014 Apr 28; 20(4):505-9. PubMed ID: 24367037 [Abstract] [Full Text] [Related]
14. New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab. Hartung HP. Lancet Neurol; 2009 Jan 28; 8(1):28-31. PubMed ID: 19081511 [No Abstract] [Full Text] [Related]
15. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. Kleinschmidt-DeMasters BK, Tyler KL. N Engl J Med; 2005 Jul 28; 353(4):369-74. PubMed ID: 15947079 [Abstract] [Full Text] [Related]
17. A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis. Holmén C, Piehl F, Hillert J, Fogdell-Hahn A, Lundkvist M, Karlberg E, Nilsson P, Dahle C, Feltelius N, Svenningsson A, Lycke J, Olsson T. Mult Scler; 2011 Jun 28; 17(6):708-19. PubMed ID: 21228027 [Abstract] [Full Text] [Related]
18. Natalizumab: bench to bedside and beyond. Rudick R, Polman C, Clifford D, Miller D, Steinman L. JAMA Neurol; 2013 Feb 28; 70(2):172-82. PubMed ID: 23128399 [Abstract] [Full Text] [Related]
19. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R. N Engl J Med; 2009 Sep 10; 361(11):1075-80. PubMed ID: 19741228 [Abstract] [Full Text] [Related]
20. Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn's disease. Ko HH, Bressler B. Expert Rev Gastroenterol Hepatol; 2007 Oct 10; 1(1):29-39. PubMed ID: 19072431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]